208 related articles for article (PubMed ID: 6252831)
1. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
Lang SD; Edwards DJ; Durack DT
Antimicrob Agents Chemother; 1980 Mar; 17(3):488-93. PubMed ID: 6252831
[TBL] [Abstract][Full Text] [Related]
2. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Hall WH; Opfer BJ; Gerding DN
Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Borobio MV; Aznar J; Jimenez R; Garcia F; Perea EJ
Antimicrob Agents Chemother; 1980 Feb; 17(2):129-31. PubMed ID: 6247966
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity of first, second and third generation cephalosporins.
Forsgren A
Acta Pathol Microbiol Scand B; 1981 Aug; 89(4):221-5. PubMed ID: 6274143
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
Kurtz TO; Winston DJ; Hindler JA; Young LS; Hewitt WL; Martin WJ
Antimicrob Agents Chemother; 1980 Oct; 18(4):645-8. PubMed ID: 6255864
[TBL] [Abstract][Full Text] [Related]
6. In vitro efficacy of cefoperazone compared with cefotaxime, LY127935, and thienamycin.
Lang SD; Durack DT
Clin Ther; 1980; 3(Spec Issue):112-6. PubMed ID: 6248219
[No Abstract] [Full Text] [Related]
7. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
Baumgärtner M; Dickgiesser N; Müller S; Wundt W
Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
[TBL] [Abstract][Full Text] [Related]
8. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Corrado ML; Landesman SH; Cherubin CE
Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
Pusztai-Markos Z; Pranada F
Eur J Clin Microbiol; 1982 Feb; 1(1):49-51. PubMed ID: 6293811
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
Jorgensen JH; Crawford SA; Alexander GA
Antimicrob Agents Chemother; 1980 Jun; 17(6):937-42. PubMed ID: 6250470
[TBL] [Abstract][Full Text] [Related]
11. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
Corser CA; Day GJ; Humble MW
N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
[TBL] [Abstract][Full Text] [Related]
12. Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
Reimer LG; Mirrett S; Reller LB
Antimicrob Agents Chemother; 1980 Mar; 17(3):412-6. PubMed ID: 6448577
[TBL] [Abstract][Full Text] [Related]
13. In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Baker CN; Thornsberry C; Jones RN
Antimicrob Agents Chemother; 1980 Apr; 17(4):757-61. PubMed ID: 6249195
[TBL] [Abstract][Full Text] [Related]
14. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
Jones RN; Fuchs PC; Sommers HM; Gavan TL; Barry AL; Gerlach EH
Antimicrob Agents Chemother; 1980 Apr; 17(4):750-6. PubMed ID: 6446880
[TBL] [Abstract][Full Text] [Related]
15. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM
Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
DeMaria A; Alvarez S; Klein JO; McCabe WR
Infection; 1980; 8 Suppl 3():S 261-7. PubMed ID: 6447671
[TBL] [Abstract][Full Text] [Related]
17. Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Miller MA; LeFrock JL; Vercler MJ
Microbiol Immunol; 1981; 25(11):1119-27. PubMed ID: 6276701
[TBL] [Abstract][Full Text] [Related]
18. Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria.
Jorgensen JH; Crawford SA; Alexander GA
Antimicrob Agents Chemother; 1980 May; 17(5):901-4. PubMed ID: 6249198
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
[TBL] [Abstract][Full Text] [Related]
20. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
Mascellino MT; Prignano G; Iegri F; Lorenzi A
Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
